Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ESTIRIPENTOL BILLEV 250 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/ESTIRIPENTOL BILLEV 250 MG CAPSULAS DURAS EFG

Approved

STANDARD

ESTIRIPENTOL BILLEV 250 MG CAPSULAS DURAS EFG

Billev Pharma Aps🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Apr 2, 2025
Approval ID: 009fb79fce8a7330
Company: Billev Pharma Aps
Type: Standard

Approval Details

Approval Id: 009fb79fce8a7330
Drug Cima Aemps Name: ESTIRIPENTOL BILLEV 250 MG CAPSULAS DURAS EFG
Register Number: 90247
Holder Company Name: Billev Pharma Aps
Marketing Company Name: Billev Pharma Aps
Holder Company Detail Path: /organization/bea362469652b287/billev-pharma-aps
Marketing Company Detail Path: /organization/bea362469652b287/billev-pharma-aps
Authorization Date: 2025-04-02
Dosage Form: CÁPSULA DURA
Dose: 250 mg
Route Of Administration: VÍA ORAL
Prescription Type: Diagnóstico Hospitalario
Commercialized: No
Company Name: Billev Pharma Aps
Company Detail Path: /organization/bea362469652b287/billev-pharma-aps

Company Information

Pharmaceutical Company Name: BILLEV PHARMA ApS
Country Name: Denmark
Website: https://billevpharma.dk

Active Ingredients

ESTIRIPENTOL

250 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Apr 2, 2025

Approval ID

009fb79fce8a7330

Type

Standard

Back to CIMA-AEMPS Approvals